JAGX vs. NDRA

In the year-to-date period, JAGX achieves a -82.57% return, which is significantly lower than NDRA's -46.49% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Jaguar Health, Inc. (JAGX) and ENDRA Life Sciences Inc. (NDRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current JAGX Sharpe Ratio is -0.73, which is lower than the NDRA Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of JAGX and NDRA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither JAGX nor NDRA has paid dividends to shareholders.

The maximum JAGX drawdown since its inception was -100.00%, roughly equal to the maximum NDRA drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for JAGX and NDRA.

The current volatility for Jaguar Health, Inc. (JAGX) is 45.28%, while ENDRA Life Sciences Inc. (NDRA) has a volatility of 69.88%. This indicates that JAGX experiences smaller price fluctuations and is considered to be less risky than NDRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Jaguar Health, Inc. and ENDRA Life Sciences Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.